136 related articles for article (PubMed ID: 22452791)
1. Identification of tristetraprolin as a factor that modulates the stability of the TAFI transcript through binding to the 3'-untranslated region.
Novakovic D; Kuo AC; Lin JH; Koschinsky ML; Boffa MB
J Thromb Haemost; 2012 May; 10(5):887-94. PubMed ID: 22452791
[TBL] [Abstract][Full Text] [Related]
2. Pro-inflammatory cytokines reduce human TAFI expression via tristetraprolin-mediated mRNA destabilisation and decreased binding of HuR.
Komnenov D; Scipione CA; Bazzi ZA; Garabon JJ; Koschinsky ML; Boffa MB
Thromb Haemost; 2015 Aug; 114(2):337-49. PubMed ID: 26062599
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor-alpha agonists repress expression of thrombin-activatable fibrinolysis inhibitor by decreasing transcript stability.
Masuda Y; Saotome D; Takada K; Sugimoto K; Sasaki T; Ishii H
Thromb Haemost; 2012 Jul; 108(1):74-85. PubMed ID: 22535242
[TBL] [Abstract][Full Text] [Related]
4. Tristetraprolin recruits functional mRNA decay complexes to ARE sequences.
Hau HH; Walsh RJ; Ogilvie RL; Williams DA; Reilly CS; Bohjanen PR
J Cell Biochem; 2007 Apr; 100(6):1477-92. PubMed ID: 17133347
[TBL] [Abstract][Full Text] [Related]
5. Nobiletin, a polymethoxyflavone in citrus fruits, reduces TAFI expression in HepG2 cells through transcriptional inhibition.
Takada K; Seike T; Sasaki T; Masuda Y; Ito A; Ishii H
Thromb Haemost; 2013 Jun; 109(6):1060-9. PubMed ID: 23572161
[TBL] [Abstract][Full Text] [Related]
6. Effect of single nucleotide polymorphisms on expression of the gene encoding thrombin-activatable fibrinolysis inhibitor: a functional analysis.
Boffa MB; Maret D; Hamill JD; Bastajian N; Crainich P; Jenny NS; Tang Z; Macy EM; Tracy RP; Franco RF; Nesheim ME; Koschinsky ML
Blood; 2008 Jan; 111(1):183-9. PubMed ID: 17855631
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the mouse gene encoding TAFI by TNFα: role of NFκB binding site.
Garand M; Lin JH; Hill CE; Zagorac B; Koschinsky ML; Boffa MB
Cytokine; 2012 Mar; 57(3):389-97. PubMed ID: 22217421
[TBL] [Abstract][Full Text] [Related]
8. PI3-Kinase Inhibitor LY294002 Repressed the Expression of Thrombin-Activatable Fibrinolysis Inhibitor in Human Hepatoma HepG2 Cells.
Masuda Y; Yazawa J; Makino Y; Takada K
Biol Pharm Bull; 2015; 38(10):1529-35. PubMed ID: 26424017
[TBL] [Abstract][Full Text] [Related]
9. Hu antigen R and tristetraprolin: counter-regulators of rat apical sodium-dependent bile acid transporter by way of effects on messenger RNA stability.
Chen F; Shyu AB; Shneider BL
Hepatology; 2011 Oct; 54(4):1371-8. PubMed ID: 21688286
[TBL] [Abstract][Full Text] [Related]
10. Role of mRNA transcript stability in modulation of expression of the gene encoding thrombin activable fibrinolysis inhibitor.
Maret D; Boffa MB; Brien DF; Nesheim ME; Koschinsky ML
J Thromb Haemost; 2004 Nov; 2(11):1969-79. PubMed ID: 15550029
[TBL] [Abstract][Full Text] [Related]
11. Acute phase mediators modulate thrombin-activable fibrinolysis inhibitor (TAFI) gene expression in HepG2 cells.
Boffa MB; Hamill JD; Maret D; Brown D; Scott ML; Nesheim ME; Koschinsky ML
J Biol Chem; 2003 Mar; 278(11):9250-7. PubMed ID: 12645517
[TBL] [Abstract][Full Text] [Related]
12. Inherent instability of plasminogen activator inhibitor type 2 mRNA is regulated by tristetraprolin.
Yu H; Stasinopoulos S; Leedman P; Medcalf RL
J Biol Chem; 2003 Apr; 278(16):13912-8. PubMed ID: 12578825
[TBL] [Abstract][Full Text] [Related]
13. Tristetraprolin regulates CXCL1 (KC) mRNA stability.
Datta S; Biswas R; Novotny M; Pavicic PG; Herjan T; Mandal P; Hamilton TA
J Immunol; 2008 Feb; 180(4):2545-52. PubMed ID: 18250465
[TBL] [Abstract][Full Text] [Related]
14. IL-17 regulates CXCL1 mRNA stability via an AUUUA/tristetraprolin-independent sequence.
Datta S; Novotny M; Pavicic PG; Zhao C; Herjan T; Hartupee J; Hamilton T
J Immunol; 2010 Feb; 184(3):1484-91. PubMed ID: 20042592
[TBL] [Abstract][Full Text] [Related]
15. Coordinated expression of tristetraprolin post-transcriptionally attenuates mitogenic induction of the oncogenic Ser/Thr kinase Pim-1.
Mahat DB; Brennan-Laun SE; Fialcowitz-White EJ; Kishor A; Ross CR; Pozharskaya T; Rawn JD; Blackshear PJ; Hassel BA; Wilson GM
PLoS One; 2012; 7(3):e33194. PubMed ID: 22413002
[TBL] [Abstract][Full Text] [Related]
16. Drosophila eyes absent is a novel mRNA target of the tristetraprolin (TTP) protein DTIS11.
Yeh PA; Yang WH; Chiang PY; Wang SC; Chang MS; Chang CJ
Int J Biol Sci; 2012; 8(5):606-19. PubMed ID: 22553461
[TBL] [Abstract][Full Text] [Related]
17. Tryptophan-Mediated Interactions between Tristetraprolin and the CNOT9 Subunit Are Required for CCR4-NOT Deadenylase Complex Recruitment.
Bulbrook D; Brazier H; Mahajan P; Kliszczak M; Fedorov O; Marchese FP; Aubareda A; Chalk R; Picaud S; Strain-Damerell C; Filippakopoulos P; Gileadi O; Clark AR; Yue WW; Burgess-Brown NA; Dean JLE
J Mol Biol; 2018 Mar; 430(5):722-736. PubMed ID: 29291391
[TBL] [Abstract][Full Text] [Related]
18. Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells.
Bourcier C; Griseri P; Grépin R; Bertolotto C; Mazure N; Pagès G
Am J Physiol Cell Physiol; 2011 Sep; 301(3):C609-18. PubMed ID: 21593445
[TBL] [Abstract][Full Text] [Related]
19. Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay.
Ogilvie RL; Abelson M; Hau HH; Vlasova I; Blackshear PJ; Bohjanen PR
J Immunol; 2005 Jan; 174(2):953-61. PubMed ID: 15634918
[TBL] [Abstract][Full Text] [Related]
20. Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA.
Dai XY; Cai Y; Sun W; Ding Y; Wang W; Kong W; Tang C; Zhu Y; Xu MJ; Wang X
Cardiovasc Res; 2014 Feb; 101(2):297-305. PubMed ID: 24253523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
